Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

SHA:603718 Revenue

Shanghai Hile Bio-Technology had revenue of 47.39M CNY in the quarter ending March 31, 2026, a decrease of -23.31%. This brings the company's revenue in the last twelve months to 173.47M, down -33.92% year-over-year. In the year 2025, Shanghai Hile Bio-Technology had annual revenue of 187.87M, down -30.69%.

• Revenue (ttm): 173.47M
• Revenue Growth: -33.92%
• P/S Ratio: 14.43
• Revenue / Employee: 473.95K
• Employees: 366
• Market Cap: 2.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	187.87M	-83.17M	-30.69%
Dec 31, 2024	271.04M	30.32M	12.59%
Dec 31, 2023	240.72M	-59.27M	-19.76%
Dec 31, 2022	299.99M	-47.30M	-13.62%
Dec 31, 2021	347.29M	88.16M	34.02%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error